RTTQA Group Vision Statement

To provide centrally co-ordinated Radiotherapy Quality Assurance for all relevant NIHR CRN portfolio trials to eliminate bias due to systematic variation in radiotherapy delivery. To enable high quality practice-changing techniques to be adopted for the benefit of cancer patients nationwide. To provide a radiotherapy data resource which will inform improvements in the wider health economy.

The RTTQA group is a centralised UK resource providing national RT QA programmes for all NIHR CRN Portfolio trials that include a radiotherapy component. The group exists as a single multi-professional network of radiographers, clinical scientists, clinicians, IT and admin staff working across a number of NHS sites

The group provides direct interaction with a trial chief investigator, the relevant clinical trials unit (CTU), the trial management group (TMG) and local centres and individually formulates a QA programme to be delivered for each trial and undertakes the processes required to fulfil the programme.

The RTTQA group monitors adherance to a trial protocol and hence serves to minimise variations ensuring clinical trial outcomes reflect differences in randomisation schedules rather than departures from the trial protocol.









There is no content in this space.